Crypto is going crazyBitcoin just lost its major daily support — but is it the end or just a reset? Let’s break down the real situation in crypto this November using data, psychology, and Dow theory.
Fundamental Analysis
Monthly Metals Analysis: Gold (XAUUSD), Issue 211 The analyst expects XAUUSD’s price to rise by the specified end time, based on quantitative analysis.
The take-profit level only indicates the potential price range during this period — it’s optional and not a prediction that price will reach it.
You don’t need to go all-in or use leverage to trade wisely.
Allocating just a portion of your funds keeps overall risk minimal.
Our approach follows institutional portfolio principles — not the all-in or blow-up trading style often seen on social media.
Results are measured over the full time window, regardless of whether the take-profit level is hit.
The validity of this analysis is based on a specific time range (until 03 Dec 2025), and after this period, the analysis will be reviewed and updated (once every 28 days).
When Does Progress Move Backward?UniQure N.V. experienced a catastrophic 75% stock plunge in November 2025 following an unexpected FDA reversal on its Huntington's disease gene therapy, AMT-130. Despite having received Breakthrough Therapy Designation and Regenerative Medicine Advanced Therapy designation, the company learned during a pre-BLA meeting that the FDA now considers its Phase I/II data, which relied on external controls from the Enroll-HD natural history database, insufficient for approval. This contradicted prior regulatory guidance and forced UniQure to abandon its planned Q1 2026 submission, immediately destroying billions in market capitalization and rendering near-term revenue projections obsolete.
The regulatory reversal reflects broader instability within the FDA's Center for Biologics Evaluation and Research (CBER), where leadership turnover and philosophical shifts have created systemic uncertainty across the gene therapy sector. New CBER leadership, particularly Director Vinay Prasad, favors traditional evidence standards over accelerated pathways that rely on surrogate endpoints or external controls. This policy hardening invalidates development strategies that biotechnology companies had pursued based on previous regulatory assurances, demonstrating that breakthrough designations no longer guarantee acceptance of innovative trial designs.
The financial consequences extend beyond UniQure's immediate valuation collapse. Every year of regulatory delay erodes patent exclusivity. AMT-130's patents expire in 2035, directly destroying net present value. Analysis suggests that a three-year delay could render 33-66% of rare disease therapies unprofitable, and UniQure now faces the prospect of funding expensive randomized controlled trials while operating with negative profit margins and declining revenues. The company's only viable hedges involve pursuing approval through European regulators (EMA) or the UK's MHRA, where regulatory philosophies may prove more accommodating.
This case serves as a critical warning for the entire gene therapy sector: accelerated approval pathways are contracting, single-arm trials using external controls face heightened scrutiny, and prior regulatory agreements carry diminishing reliability. Investors must now price significantly higher regulatory risk premiums into biotech valuations, particularly for companies dependent on single assets and novel trial methodologies. The UniQure experience confirms that in biotechnology investment, regulatory predictability, not just scientific innovation, determines commercial viability.
Pi Coin Price Approaches $0.20 — Another Sideways Phase?Pi Coin’s price has declined by nearly 16% over the past week after failing to breach the $0.260 resistance. At the time of writing, the altcoin is trading at $0.220, reflecting its weakening technical position amid fading market support and declining investor optimism.
If the downward trend persists, Pi Coin’s price could fall below $0.209 and reenter a consolidation zone between $0.209 and $0.198. This pattern, seen previously, could stall recovery attempts and extend the bearish phase for a few more weeks.
However, a bounce from current levels could shift momentum. If Pi Coin reclaims $0.229 as support, it could attempt a rally toward the $0.246 resistance. Sustaining inflows and investor interest will be critical to invalidating the bearish outlook.
Bitcoin Losses Hit 9-Month High Of $24 Billion Amid 8% Price DroBitcoin is trading at $101,729 at the time of writing, sitting just above the critical $100,000 support. Earlier, BTC slipped below this level, forming an intra-day low of $98,966 before rebounding slightly.
The recent 8% drop has validated a head-and-shoulders pattern, which projects a potential 13.6% decline targeting $89,948. However, if investors begin buying at lower levels, Bitcoin could bounce from $100,000 and retest $105,000 or higher.
Conversely, continued selling pressure and weak market conditions could send BTC below $100,000 again. A breach under $98,000 may lead to further losses toward $95,000 or lower, undermining any short-term recovery hopes.
AUDCAD November 2025 fundamental analysisAustralian Dollar (AUD): Inflation Surprise Supports Hold
Reserve Bank of Australia Stance
The Australian Dollar received a powerful boost from the September quarter inflation data released on October 29, which delivered a significant upside surprise. Headline CPI accelerated to 1.3% quarter-on-quarter and 3.2% year-on-year, well above the RBA's 2-3% target midpoint. More importantly, the RBA's preferred trimmed mean measure climbed 1.0% quarterly (beating 0.8% expectations and the RBA's August forecast of 0.6%), pushing the annual rate to 3.0%—the first uptick since December 2022.
RBA Governor Michele Bullock had explicitly stated earlier in the week that a 0.9% quarterly rise in trimmed mean inflation would be viewed as a "material miss". At 1.0%, the threshold was decisively crossed. Bullock also described the labor market as "a little tight" despite unemployment rising to 4.5%, and emphasized the RBA's unwillingness to "leap at a single number".
Rate Cut Expectations Pushed Back
The inflation surprise has dramatically reshaped rate cut expectations. The November 4 meeting confirmed the decision to hold rates steady for the moment, and the first 25 basis point cut has been delayed from February 2026 to May 2026. This represents a stark shift from earlier expectations for near-term easing. The RBA cash rate remains at 3.60%, providing a substantial yield advantage over other major central banks.
November Outlook: Very Bullish
The Australian Dollar is the clear standout for November strength. AUD/USD surged to a three-week high of 0.6607 following the inflation data, and technical analysis suggests further upside potential toward 0.6706. The currency benefits from multiple tailwinds: delayed rate cuts relative to other central banks, particularly the Fed; buoyant risk sentiment following the preliminary US-China trade framework; and strong commodity prices, including copper near three-month highs. Against the weaker commodity currencies like CAD and NZD, the Australian Dollar is exceptionally well-positioned.
Canadian Dollar (CAD): Economic Headwinds and Continued Easing
Bank of Canada Policy
The Bank of Canada delivered another 25 basis point rate cut at its October 29 meeting, bringing the policy rate to 2.25%. This continues an aggressive easing cycle that has seen rates reduced by 225 basis points since June 2024, from a peak of 4.50% to the current 2.75%. Markets are pricing in current easing for the October meeting despite recent data showing 60,000 employment gains and headline inflation rising to 2.4%.
Economic Challenges
The BoC's dovish stance is driven by persistent concerns about the Canadian economic outlook. The third-quarter Business Outlook Survey showed that uncertainty around trade policy continues to weigh heavily on investment and hiring plans. The "future sales" indicator dropped back into negative territory for the first time in 2025, and 63% of firms expect either unchanged or reduced workforce levels—levels historically associated with unemployment rates of 7.3% or higher.
Canada's terms of trade have deteriorated significantly, with crude oil prices falling to multi-month lows. WTI crude is trading around $59-60 per barrel, down from earlier highs, removing a key pillar of support for the loonie.
November Outlook: Bearish
The Canadian Dollar faces a challenging November. USD/CAD has moved higher to the 1.40 handle, and while some analysts expect a return to 1.38 by year-end driven primarily by USD weakness, the path may be slow with potential spikes to 1.41. The loonie is expected to underperform against most G10 currencies, given the BoC's continued easing path and Canada's vulnerability to weak energy prices.
Verdict
Given these grave fundamental divergences between AUD and CAD the current assessment for AUD/CAD is a clear BUY .
WTI It's creating an Invers Head and Sholders pattern-At this price It's a very good opportunity to enter with a very good SL and a high profit opportunity.
-Currently It's bullish as the chart show us but It's important to be very carrefull cause petrol It's very volatile and political influenced
USD/CAD pair It's currently very bullish- the bullish trend currently feels very strong on this pair, I like it for a longer period of time cause USD It's getting bullish against other currencies and CAD shows quite week on the chart
- A very nice opportunity for the current month with adding new long positions after the corrections based on previous long trend
- After Wednesday rate cuts the USD will just continue to get stronger against the CAD and other currencies
let me know also your opinion in the comments bellow.
$XRP in a major accumulation area.CRYPTOCAP:XRP in a major accumulation area.
Wyckoff Method Scenario Repeating.
XRP is trading in a classic Accumulation Phase according to the Wyckoff method.
Technically, this structure is leading to a strong bullish cycle.
Following a similar accumulation period in 2017, XRP began a parabolic run and rose to the Distribution zone.
Altcoins \ Altseason Others / BTC ratio is in its lowest momentum zone in history...
Historic demand area has been tested once again, marking the final phase of capitulation.
Every major altcoin season has begun with just such silence.
What's coming will explain the silence.
MY THOUGHT AND SHORT VIDEO ABOUT GOLD📊 XAAUSD Analysis – CMP Zone Setup
I expect XAAUSD to test the zone, based on my CMP (Current Market Price) technique — a method I use to identify potential reaction areas and key levels from a technical perspective.
🔍 Technical Outlook:
Price is approaching a CMP zone that may act as a reaction point.
I’ll be monitoring closely for a bearish engulfing pattern as confirmation before entering a trade.
🎯 Trade Plan:
Stop Loss: 50 pips
Take Profit: 1:2 or 1:3 R:R
Setup Type: CMP Reaction + Engulfing Confirmation
⚠️ Disclaimer:
This analysis reflects my personal technical view and is not financial advice. Always do your own research before taking any trade.
Dxy will fall in coming months Crypto will Rise.Dxy Target of 92 is going to happen in coming months blow off top will happen before bear market starts.
Kimberly-Clark Enters the Healthcare BusinessKimberly-Clark Enters the Healthcare Business with the Acquisition of Kenvue
By Ion Jauregui – Analyst at ActivTrades
Kimberly-Clark (NYSE: KMB), traditionally associated with consumer products such as Kleenex and Huggies, has made its most ambitious move in decades with the acquisition of Kenvue (NYSE: KVUE) for more than $40 billion. With this deal, the company fully enters the pharmaceutical and healthcare sector, betting on the stability of demand in an increasingly uncertain economic environment.
Kenvue, spun off from Johnson & Johnson, brings a portfolio of iconic brands such as Band-Aid, Listerine, Neutrogena, and Tylenol — all with a strong global presence and above-average margins within the consumer staples segment. For Kimberly-Clark, the transaction not only diversifies its portfolio but also strengthens its presence in the over-the-counter (OTC) product segment, an area growing in line with population aging and increasing healthcare spending in the United States and Asia.
However, the move carries built-in risks: Kenvue faces lawsuits over an alleged link between Tylenol use and prenatal complications — a factor that could result in additional provisions and short-term pressure on cash flow. Even so, industry analysts view the acquisition as a long-term defensive play that will allow KMB to balance revenues against the volatility of traditional consumer goods.
Fundamental Analysis
Kimberly-Clark currently trades around $123 per share (as of November 4, 2025), with a market capitalization of approximately $41 billion. Its P/E ratio stands at around 22x earnings, slightly above the consumer staples sector average, but with projected revenue growth of 6% for 2026, driven by the integration of Kenvue and expansion into the health and wellness division.
The dividend yield remains solid at around 3.8%, reflecting the company’s longstanding commitment to shareholder returns. In the short term, net debt will rise due to the acquisition financing, but the expected operating cash flow (over $4 billion annually) should allow for gradual deleveraging starting in 2026. Market consensus remains neutral to slightly bullish, with an average price target of $135, based on projected synergies with Kenvue and margin improvement within the healthcare product line.
Technical Analysis
From a technical perspective, KMB traded in a sideways structure from mid-2024 to mid-March this year. Since late March, however, the trend has turned clearly bearish. Monday’s gap-down opening added further pressure, bringing the stock back to September 2023 price levels. Yesterday’s close consolidated around $100. Moving average crossovers indicate a strong downward trend. The RSI is deeply bearish, in oversold territory at 20%, and the MACD shows a bearish trend with a negative histogram. The acquisition of Kenvue appears to have weighed heavily on the stock price.
The ActivTrades US Market Pulse indicator points to a neutral zone with a risk-off bias, suggesting that part of the recent sell-off may be due to institutional position liquidations. What’s clear is that the stock now appears to be trading at a potential discount given its fundamental outlook.
Kimberly-Clark is making it clear that its ambitions go well beyond tissues and diapers: it aims to compete at the core of the everyday pharmaceutical business — where recurrence and margins reign. If it successfully integrates Kenvue and manages its legal exposure, 2026 could mark the beginning of a new era of sustained growth for the veteran American company.
*******************************************************************************************
The information provided does not constitute investment research. The material has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and such should be considered a marketing communication.
All information has been prepared by ActivTrades ("AT"). The information does not contain a record of AT's prices, or an offer of or solicitation for a transaction in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information.
Any material provided does not have regard to the specific investment objective and financial situation of any person who may receive it. Past performance and forecasting are not a synonym of a reliable indicator of future performance. AT provides an execution-only service. Consequently, any person acting on the information provided does so at their own risk. Political risk is unpredictable. Central bank actions can vary. Platform tools do not guarantee success.
Dollar Rises Amid Record US Shutdown and Liquidity ShortageThe dollar index is climbing as the US faces its longest government shutdown on record. The FRED:SOFR rate is trading 0.23 percentage points above the FRED:IORB , signaling a liquidity shortage. Unfortunately, TradingView data doesn’t cover the 2019 liquidity crunch, but the current situation looks similar.
Earlier this week, Logan highlighted the elevated repo rate and noted that the Fed may need to step in and purchase assets if conditions persist. The liquidity shortage is putting upward pressure on the dollar index. A breakout above 101 could accelerate that pressure further.
If the US shutdown ends, renewed government spending could ease the liquidity strain, allowing the dollar to retreat. Until then, upward momentum is likely to continue.
Today's behavior of the Dollar-Yen news timeHello
Red levels are good resistances and green levels are good support near the price.
The downtrend line has also been drawn.
Today we have important dollar news on the status of non-farm payrolls, which, given the history of the announced numbers, seems to be in the direction of weakening the dollar and strengthening the dollar-yen currency pair.
So I expect a good reaction to the current resistance and finally confirmation to enter the sell position has been drawn.
Don't forget about money management.
Good luck.
DXY — London SessionThe Dollar reached its 99.8 target and closed the day above it, confirming short-term strength. Price now trades stretched on the daily chart, well above its normal rhythm. As long as daily lows keep printing higher, structure holds — but with both weekly and monthly charts in correction, momentum could fade quickly. This is a day-by-day market where clarity matters more than conviction.
On the technical side, DXY shows rhythm exhaustion — clear deviation from its average range. When price moves this far from balance, professionals stop chasing and wait for rhythm to reset. The key signal now is whether the next daily low holds or breaks; that decides who controls the tape.
Macro conditions still support the Dollar. The Fed’s tone stays cautious on further cuts, while the U.S. government shutdown keeps data flow limited. Investors prefer safety over yield, and capital continues to park in USD for clarity and liquidity. It’s not a growth story — it’s a stability story.
When a target hits, professionals re-map before acting again. The next decision comes from structure, not emotion.
Operator Rule: After targets hit, think — don’t chase.
- Institutional Logic. Modern Technology. Real Freedom.
buy gold sell eurgold looking very solid and gold rallye seems to just getting started, the momentum in gold is huge and unbroken, set-backs are very small in price and corrections are brief, short-term and structural very stable. meanwhile euro is under immense geopolitical pressure and insecurities, gold seems to be a far better alternative to it
Nikkei 225 Plunges from Record HighNikkei 225 Plunges from Record High
As the chart shows, the Nikkei 225 stock index formed a historic peak around 52,500 points only yesterday — but today it has fallen sharply, with losses at the session low reaching approximately 7%.
Bearish sentiment was fuelled in part by a slump in shares of Japanese investment giant SoftBank, which dropped by around 14%. The company’s heavy exposure to sectors linked to artificial intelligence and cryptocurrencies, both currently under pressure, has raised investor concerns.
The decline in the Nikkei 225 appears to be an extension of the sell-off in US technology stocks recorded yesterday, driven by a stronger dollar and growing fears of an AI-fuelled bubble.
Technical Analysis of the Nikkei 225 Chart
As shown by the 200- and 400-period moving averages on the 4-hour chart, Japan’s equity market remains in a long-term uptrend, with the widening gap between the two lines signalling an acceleration in growth. This supports the relevance of two upward channels:
→ a long-term channel, shown in blue;
→ an intermediate channel, marked by orange lines with a steeper gradient.
It is noteworthy that at the start of November, the Nikkei 225 entered the zone where the upper boundaries of both channels intersect – unsurprisingly, this confluence of resistance lines triggered a wave of selling pressure.
Key observations:
→ Sellers succeeded in pushing the price down towards the lower orange line, which acted as strong support, similar to the movement seen between 10–12 October (indicated by arrows on the chart);
→ Today, the price made a false bearish breakout below the psychological 50,000 level, forming a candle with a long lower shadow – a sign of buying interest.
Given the above, it is reasonable to assume that the market may attempt to resume its upward trajectory. Should this scenario play out, we could see signs of rally exhaustion, as the upward movement that began in April has already lifted the Nikkei 225 by more than 280%.
This article represents the opinion of the Companies operating under the FXOpen brand only. It is not to be construed as an offer, solicitation, or recommendation with respect to products and services provided by the Companies operating under the FXOpen brand, nor is it to be considered financial advice.
Gold market extends its bearish momentumGold market extends its bearish momentum, with price action now pushing towards the 3920’s. Following rejection from the 4000’s, sellers maintain dominance as liquidity continues to shift lower. follow for more insight , comment and boost idea
Gold take youR BUYAs crypto is getting crashed we see a lot of momentum in Gold vice versa and it's time for some new upward momvemnt ; it's good for byer who,like to capitalize
XAUUSD XAU/USD – Gold Analysis
Gold could rise toward the 3997–4000 zone to complete the fractal and retest the descending trendline forming the bearish channel. From that area, I’ll look for short opportunities, expecting a move toward the lower part of the ascending trendline.
Yesterday, price strongly rejected the midline of the ascending channel, which confirms continued short pressure for now. Ideally, I’d like to see gold reach 3955, where it could find support and resume the broader bullish channel.
Fundamental Outlook:
The U.S. dollar remains firm, supported by rising Treasury yields and reduced expectations of near-term Fed rate cuts.
Ongoing geopolitical tensions have added some volatility, but risk appetite has improved slightly, reducing demand for gold as a safe haven.
U.S. economic data continues to show resilience, giving the Fed room to keep policy restrictive — a factor that typically limits gold’s upside.
However, any signs of weaker U.S. data or renewed global uncertainty could quickly support gold again, especially if the 3950–3960 area holds as strong demand.
Summary:
📈 Possible rise to 3997–4000 → looking for short setups.
🎯 Downside target: 3955 (trendline support).
💡 Bias: Short-term bearish, medium-term bullish above 3950.
⚙️ Fundamentals: Strong USD and yields keep gold pressured for now.
EUR/USD Technical Analysis – November 5, 2025Price overview:
EUR/USD remains under bearish pressure, trading below multiple key resistance levels after a clear downward continuation from the 1.1580 – 1.1600 zone. The market structure shows consistent lower highs, reflecting the strength of sellers on intraday timeframes.
Technical outlook:
Price has recently formed a minor consolidation range near 1.1480 – 1.1500, signaling potential continuation before the next impulse.
Three major resistance levels to note:
1.1505 – 1.1520: Immediate intraday resistance zone (current retest area).
1.1555 – 1.1570: Previous supply area and unmitigated order block.
1.1600 – 1.1620: Higher-timeframe structural resistance.
Support area: The next significant level sits at 1.1455 – 1.1445, coinciding with a liquidity pocket and previous demand reaction.
Trading strategy:
Main scenario (Sell bias):
→ Look for bearish confirmation around 1.1500 – 1.1520, ideally after a fake breakout or rejection wick.
→ Sell entry: 1.1500
→ Stop loss: Above 1.1525
→ Take profit: 1.1455 / 1.1445
The risk–reward ratio remains favorable if momentum continues in line with the overall bearish structure.
Alternative scenario (Reversal potential):
→ A confirmed breakout and hold above 1.1555 would invalidate the bearish bias and shift focus toward 1.1600.
Indicators & confluence:
Price remains below the EMA50, maintaining bearish alignment on H1.
RSI currently hovers near the neutral zone (~50), suggesting room for another push downward before oversold conditions develop.
Key levels to monitor:
Resistance: 1.1505 / 1.1555 / 1.1600
Support: 1.1455 / 1.1445
Conclusion:
EUR/USD continues to trade within a controlled bearish rhythm, and the 1.1500 – 1.1520 zone remains critical for short-term direction. Traders should watch closely for rejection patterns to confirm potential downside continuation.
Stay disciplined and follow the structure—reaction at key zones will reveal the next move.
Save this setup and follow for more daily strategy updates.
